Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

FDA Clears Zeiss Ocular Imaging System

Facebook Twitter LinkedIn Email
Carl Zeiss Meditec AG has received FDA clearance for its PLEX Elite 9000 Swept-Source OCT posterior ocular imaging system, expanding the potential for clinical researchers to open new frontiers of discovery in diseases affecting the retina.

The PLEX Elite 9000 offers researchers the potential to assess early mechanisms for micro- and neovascularization, explore the progression of retinal and choroidal pathology, deepen the understanding of choroid physiopathology and to evaluate mechanisms of retina and choroid response to therapy. The wide-field high-resolution visualization provided by the platform expands clinicians’ ability to examine the critical microstructures and microvasculature of the posterior segment at any depth of interest from vitreous to sclera.

Carl Zeiss Meditec is a medical technology company that supplies innovative technologies and application-oriented solutions.

Jan 2017
Carl Zeiss MeditecFDAPLEX Elite 9000swept-source OCTocular imagingEuropeAmericasBusinessBiophotonicsimagingRapidScan

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2023 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.